The objective of the Center of Cancer Nanotechnology Excellence is to integrate nanotechnology-based diagnostic and therapeutic tools for comprehensive cancer care. We envision a set of integrated nanotechnology-based solutions for diagnosis, therapy, and post-therapy monitoring. Combining novel in vitro assays with targeted chemotherapy and immunotherapy we can establish a new paradigm in cancer nanomedicine. Our overall objective is to demonstrate that nanotechnology-based tools can be integrated for comprehensive cancer care.
- Project 1: Screening DNA Methylation in Bodily Fluids for Early Cancer Diagnostics and Post-therapy Monitoring
- Project 2: Systemic Nanocurcumin for Pancreatic Cancer Therapy
- Project 3: Non-Invasive Quantification of Vaccine-mediated Antigen Delivery to Lymph Node by Magnetic Resonance Imaging
- Project 4: Mucus Penetrating Nanoparticles for Small Cell Lung Cancer